Elizabeth A. Lendermon - Publications

Lung Transplant Go (LTGO): A Randomized Controlled Trial to Evaluate the Efficacy of a Telerehabilitation Behavioral Exercise Intervention after Lung Transplantation.

Journal: International journal of telerehabilitation

Published: July 02, 2026

Characterization of Spirometric Response to Standard-of-care Treatment in Lung Allograft Recipients With Bronchiolitis Obliterans and the Utility of Spirometric Criteria for Rescue Therapy: Implications for the Design of Risk-stratified Clinical Trials.

Journal: Transplantation

Published: October 01, 2025

Immune gene correlation networks differentiate both chronic lung allograft dysfunction and survival.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: August 26, 2025

Identification of Surrogate Outcome Biomarkers in Lung Allograft Recipients With Bronchiolitis Obliterans: Implications for Randomized Controlled Trials.

Journal: Transplantation direct

Published: May 02, 2025

The use of bilateral orthotopic lung transplantation in the management of acute severe drug-induced interstitial lung disease: A case report.

Journal: JHLT open

Published: March 27, 2025

Pulmonary Immunocompromise in Solid Organ Transplantation.

Journal: Clinics in chest medicine

Published: January 31, 2025

Therapy With Allogeneic Severe Acute Respiratory Syndrome Coronavirus-2-Specific T Cells for Persistent Coronavirus Disease 2019 in Immunocompromised Patients.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 28, 2023

Design of Lung Transplant Go (LTGO): A randomized controlled trial evaluating the efficacy of a telerehabilitation behavioral exercise intervention to improve physical activity, physical function, and blood pressure control after lung transplantation.

Journal: Contemporary clinical trials communications

Published: September 15, 2022

CD4+ T-Cell Dysfunction in Severe COVID-19 Disease Is Tumor Necrosis Factor-α/Tumor Necrosis Factor Receptor 1-Dependent.

Journal: American journal of respiratory and critical care medicine

Published: March 29, 2022

Induction Strategies in Lung Transplantation: Alemtuzumab vs. Basiliximab a Single-Center Experience.

Journal: Frontiers in immunology

Published: January 28, 2022

Modulation of tissue resident memory T cells by glucocorticoids after acute cellular rejection in lung transplantation.

Journal: The Journal of experimental medicine

Published: October 04, 2021

Risk factors of bronchial dehiscence after primary lung transplantation.

Journal: Journal of cardiac surgery

Published: September 07, 2021